BTT-3034
BTT-3034, a sulfonamide derivative, is an α2β1 integrin inhibitor. BTT-3034 inhibits cell adhesion to rat tail collagen I with an EC50 of 160 nM and a corresponding Emaxof 86%. BTT-3034 inhibits collagen binding by an α2 variant carrying the conformationally activating E318W mutation[1].
Product Specifications
CAS Number
1259029-47-4
UNSPSC
12352100
Target
Integrin
Related Pathways
Cytoskeleton
Field of Research
Cardiovascular Disease
Smiles
O=C(NC1=CC=C(N(S(=O)(C2=CC=C(C3=CC=NN3C)S2)=O)C)C=C1)NC4=CC=CC=C4
Molecular Formula
C22H21N5O3S2
Molecular Weight
467.56
References & Citations
[1]Nissinen L, et al. Novel α2β1 integrin inhibitors reveal that integrin binding to collagen under shear stress conditions does not require receptor preactivation. J Biol Chem. 2012 Dec 28;287 (53) :44694-702.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FT313A0328_1T41C Pack of 100
Pack of 100 Filter Discs For Clarification, 328/41 Mm
Sign In for Pricing
View Details LV750353 1.0 µg DNA
TGCT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
K0199-24P 50 µg
KRT19 (Keratin, Type I Cytoskeletal 19, Cytokeratin-19, CK-19, Keratin-19, K19) discontinued
Sign In for Pricing
View Details